The Aneurysm Information Project

  • To return to the home page, click here
    Papers of the Month - January 1997
    
    
    1. Blum U, et al.  Endoluminal stent-grafts for
    infrarenal abdominal aortic aneurysms.  NEJM  1997;
    336:13-20.
    
    Abstract: A prospective study of a prosthesis made of
    nitinol and covered with polyester fabric...  154
    patients: 21 straight grafts and 133 bifurcated grafts. 
    CAT & intraarterial angiography performed at an average
    follow-up of 12.5 months.  Results: Complete exclusion of
    the AAA was achieved in 86% of the straight graft group
    and 87% of the bifurcated graft group.  The procedure was
    converted to open repair in 3 patients.  Minor (n=13) or
    major (n = 3) complications (including one death)
    occurred in 10%.  All patients had a postimplantation
    syndrome, with leukocytosis and elevated CRP.
    
    2. Yusuf et al.  Early results of endovascular aortic
    aneurysm surgery with aortouniiliac graft, contralateral
    iliac occlusion, and femorofemoral bypass.  J Vasc Surg 
    1997; 25: 165-172.
    
    Abstract: 30 patients: mean age 72, mean AAA diam 6 cm
    (range, 4-9), 28 elective procedures and 2 urgent for
    leak.  A modified Gianturco stent, Dacron graft, and
    Wallstent were used for the procedures.  Results:
    Endovascular repair was successful in 25/30 patients
    (83%).  These 25 patients were mobile and on normal diet
    within 48 hours.  There were two deaths; one in elective
    group (3.3%) and one in ER group (50%).  Overall
    morbidity occurred in 4 patients (13.3%).  At a median
    follow-up of 4 months, 27 out of 30 patients were alive
    and well.
    
    3. Matsumura JS, Pearce WH, McCarthy WJ, and Yao JST for
    the EVT Investigators.  Reduction in aortic aneurysm
    size: Early results after endovascular graft placement. 
    J Vasc Surg 1997; 25: 113-23
    
    Abstract: CT scans were done in 34 patients at an
    interval of 1 yr following stent grafting.  20 patients
    had no perigraft leaks.  7 patients had an early leak
    that sealed, and 7 patients had persistent perigraft
    leaks.  The proximal neck remained stable, but the distal
    neck enlarged by .12 cm +/- .27 cm.  AAA diameter
    decreased in those with no leak or sealed leak.  Sac
    diameter increased in the seven with perigraft leaks.  
    
    Comment by mdt - 
    
    Perhaps even more informative than the papers themselves
    are the companion pieces; specifically, the Editorial by
    Cal Ernst in NEJM and the complete transcript of the
    discussion from the floor at the SVS meeting where the
    Matsumura paper was presented.  Ernst puts it very
    succinctly: "Attractive as endovascular treatment of AAA
    may seem, its feasibility, safety, effectiveness, and
    durability are as yet unproved."  Ernst notes that to
    date there has still been no prospective randomized trial
    to compare endovascular with conventional techniques.  
    
    Many of the pioneers of endovascular repair were present
    at the SVS meeting.  Tom Fogarty mentioned "another
    alarming potential situation... in which a leak is not
    identified and yet the aneurysm continues to enlarge", a
    situation that has been observed in the thoracic
    experience at Stanford.  Jeb Hallett observed that
    bifurcated grafts may not solve the problem of an
    enlarging distal neck, unless brought down to the
    external iliacs, which in turn would risk mesenteric
    ischemia.  Juan Parodi, the first person to do an
    endovascular graft in 1991 and accordingly the surgeon
    with the longest experience, stated that he had seen
    distal dilatation and leaks even after 3 years.  IMHO,
    the endovascular approach may now be recommended for
    elderly patients who pose high or prohibitive surgical
    risk.  However, younger patients who are fit for surgery
    are usually cured by the conventional surgical approach. 
    The same cannot be presently said for endovascular
    repair.
    
    I can't resist speculating about why the sac gradually
    shrinks long term in most patients with successful seals. 
    Preliminary experiments in our lab suggest that there may
    be several autoantigens involved in the inflammatory
    changes that occur in non-specific AAA's.  One or more of
    these may be an aorta-specific matrix cell adhesion
    molecule.  If it is produced by cells in response to
    cyclic deformation, the signal for its production would
    be abrogated by a successful seal.  Then, the autoimmne
    response would down-regulate and the wall should shrink.